Wolverine Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Wolverine Trading's JAZZ Position: Q1 2025 in Review
Wolverine Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 8,988 shares — an estimated $1.11M sold.
Wolverine Trading first reported a position in JAZZ in Q1 2017 and held it in 13 quarters. The position peaked at $1.89M in Q2 2021. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.
- Wolverine Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Wolverine Trading sold 8,988 Jazz Pharmaceuticals shares in Q1 2025, an estimated $1.11M.
- Wolverine Trading first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 13 quarters.
- Wolverine Trading's Jazz Pharmaceuticals position peaked at $1.89M in Q2 2021.
- 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.
Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.